Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial

INTRODUCTION: Carnosine, an over the counter food supplement, has been shown to improve glucose metabolism as well as cardiovascular risk factors in animal and human studies through its anti-inflammatory, antioxidative, antiglycating and chelating properties. The aim of this study is to establish if...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Kirthi, Cameron, James D, de Courten, Maximilian, de Courten, Barbora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126302/
https://www.ncbi.nlm.nih.gov/pubmed/33986049
http://dx.doi.org/10.1136/bmjopen-2020-043680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126302/
https://www.ncbi.nlm.nih.gov/pubmed/33986049
http://dx.doi.org/10.1136/bmjopen-2020-043680

Ejemplares similares